Milk Thistle Silymarin: Silymarin: Milk Thistle's Active Complex for Liver Protection
⚡ 60-Second Summary
Silymarin is not a single compound but a complex of flavonolignans extracted from milk thistle seeds: silybin A and B (the most bioactive, ~50% of silymarin), isosilybin A and B, silychristin, silydianin, and the flavonoid taxifolin. Silybin (silibinin) is responsible for most hepatoprotective activity. The complex works synergistically — individual components have less hepatoprotective activity than the whole complex.
Best-evidenced uses: Identical to milk thistle overall — liver enzyme normalization in NAFLD, alcoholic liver disease, viral hepatitis, and toxic liver injury. This page focuses on the silymarin complex's pharmacology, standardization, and forms-specific information. See the Milk Thistle page for the full clinical evidence review.
Practical note: When evaluating milk thistle products, the relevant metric is silymarin content per dose (not raw milk thistle seed weight). Standardization to ≥70% silymarin ensures consistent silybin delivery. Phytosomal silybin (Siliphos, Legasil) dramatically improves bioavailability by incorporating silybin into a phosphatidylcholine complex — preferred for serious liver disease applications.
What is Milk Thistle Silymarin?
Silybin (the primary component) has three main mechanisms: competitive inhibition of hepatocyte toxin transporters (OATP1B1, OATP2B1), blocking hepatotoxin entry into liver cells; RNA polymerase I activation, stimulating ribosomal RNA synthesis and hepatocyte protein production for cell repair; and NF-κB pathway inhibition, reducing inflammatory gene expression and fibrosis. The anti-fibrotic effect is increasingly recognized as important for NAFLD and cirrhosis management.
The silymarin complex was first isolated and characterized in Germany by Hans Wagner in 1968 at the University of Munich. Legalon (standardized silymarin extract) was developed from this research and has been a licensed hepatoprotective drug in Germany since the 1970s. Clinical research on silymarin is most extensive in German and Italian medical literature, with hundreds of trials conducted from the 1970s through the present.
Evidence-based benefits
1. Silybin bioavailability challenge
Plain silymarin has poor water solubility and variable gastrointestinal absorption (~25–50%). Phytosomal silybin addresses this — bioavailability increases ~10-fold with phosphatidylcholine complexation, making phytosomal silybin essential for liver disease applications.
2. Antifibrotic effects
Silymarin inhibits TGF-β1 signaling and stellate cell activation — key drivers of liver fibrosis. Multiple human trials show reduced hydroxyproline and other fibrosis markers with long-term silymarin use.
3. Silybin vs. silymarin standardization
'70% silymarin' means 70% of the extract is silymarin by weight, of which ~50% is silybin. A 200 mg capsule of 70% silymarin extract contains ~70 mg silybin equivalent — the relevant pharmacological component.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Silymarin extract (70–80% standardized) | 420–600 mg/day | General liver support, NAFLD | Standard form; adequate for most supplementation purposes. |
| Phytosomal silybin (Siliphos) | 120–240 mg silybin equivalents/day | Advanced liver disease, cirrhosis, hepatitis | 10× bioavailability; preferred for serious liver disease. |
| Silibinin dihydrogen succinate (IV form) | IV only | Acute mushroom poisoning, severe hepatitis | Not available OTC; administered in hospital for acute hepatotoxicity. |
How much should you take?
- Standard liver support: 420–600 mg/day 70% silymarin extract
- Advanced liver disease: 100–200 mg/day phytosomal silybin
- Take with meals containing fat for improved absorption
Safety as per milk thistle — excellent. Main concern is CYP450 modulation at high doses. Phytosomal forms at higher clinical doses have more interaction potential due to greater bioavailability.
Safety and side effects
Common side effects
- GI upset (uncommon)
- CYP3A4, CYP2C9 modulation — more clinically relevant at phytosomal doses
- Ragweed/Asteraceae allergy — possible cross-reactivity
Serious risks
Well-tolerated with excellent safety profile. People on immunosuppressants, anticoagulants, or HIV medications should confirm CYP450 interaction safety with their pharmacist.
Drug and nutrient interactions
- Same drug interactions as milk thistle — silymarin IS milk thistle's active compound; CYP3A4, CYP2C9, P-gp modulation applies
- Immunosuppressants, warfarin, HIV medications — monitor at therapeutic doses
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| People with NAFLD, elevated liver enzymes, or alcoholic liver disease | People on multiple CYP-metabolized medications — check interactions |
| Those who want to understand the active chemistry behind milk thistle | People with Asteraceae allergy |
| Patients with hepatitis B or C seeking adjunct liver support |
Frequently asked questions
What is the difference between silymarin and milk thistle?
Milk thistle is the plant (Silybum marianum); silymarin is the active flavonolignan complex extracted from its seeds. When you buy 'milk thistle extract,' you are buying a silymarin-rich extract. The standardization percentage (70–80% silymarin) tells you how much of the extract is the active silymarin complex. Products labeled only in mg of 'milk thistle seed' without silymarin standardization are difficult to dose accurately.
Why is phytosomal silybin better?
Plain silymarin is poorly water-soluble and absorbed variably. Phytosomal silybin (Siliphos, Legasil) combines silybin with phosphatidylcholine, which dramatically improves oral absorption by enhancing intestinal uptake through lipid transport pathways. Bioavailability increases approximately 10-fold. For serious liver disease applications (hepatitis, cirrhosis), phytosomal forms provide therapeutically relevant tissue levels that plain silymarin cannot.
See the main Milk Thistle page for the complete clinical evidence review, FAQ, and interaction details.
Related ingredients
Milk Thistle (Full Review)
Complete evidence review with all clinical applications.
Artichoke Leaf Extract
Complementary liver support with different mechanism.
NAC (N-Acetyl Cysteine)
Glutathione precursor for liver and antioxidant support.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.